This aligns with previous studies showing F10′s superior efficacy due to its polymeric structure, efficient conversion to FdUMP, and dual inhibition of thymidylate synthase and topoisomerase I across multiple cancers, including CRC [59,61,62,90,91,92,93]. The gene discussed is TYMS; the disease is colorectal carcinoma.